LOS ANGELES--(BUSINESS WIRE)--Dr. Joel Aronowitz, leading Beverly Hills plastic surgeon and founder of the University Stem Cell Center in Los Angeles, today announced the approval of a unique clinical trial to test the effectiveness of a woman’s own adipose stem cells for breast augmentation.
The clinical study will investigate the effectiveness of adipose stem cells to grow fat tissue for cosmetic breast enlargement by measuring the results of breast augmentation using autologous fat harvested with liposuction versus augmentation through fat grafting with stem cell-enriched autologous fat.
“We’re particularly excited about this recently-approved study because we will now have the opportunity to examine just how effective stem cell-enriched fat is in producing naturally-enhanced volume in the breasts,” said Dr. Aronowitz, former Chief of the Division of Plastic Surgery for Cedars-Sinai Medical Center. “With more and more women searching for a natural alternative to foreign breast implants, fat transfer to the breasts using fat harvested with liposuction has become a viable option. As the popularity of this procedure continues to rise, this new trial may uncover the benefits and advantages of designing these fat grafts at the cellular level.”
Dr. Aronowitz initiated a separate clinical study in 2011 with a highly-publicized reconstructive stem cell procedure involving actress and health advocate Suzanne Somers. Following a disfiguring lumpectomy and radiation treatments that treated her stage-1 breast cancer over twelve years ago, Somers turned to Dr. Aronowitz to perform a breast reconstruction utilizing adipose-derived stem cells as the first case in the trial. Following the procedure, Somers openly discussed the remarkable results of her procedure in many public appearances and devoted a section to the technology in her most recent book, Bombshell: Explosive Medical Secrets That Will Redefine Aging.
“Our team has worked very hard over the past several years to reveal the benefits of stem cell technology for a variety of regenerative purposes, and the results of the study that I initiated with Suzanne, which focuses on stem cell breast reconstruction following cancer surgery and radiation, have been very positive,” said Dr. Aronowitz. “Based on what we’re uncovering, stem cell-enriched fat transfer is going to become increasingly popular for a variety of purposes. Our new study will shed even greater light on this emerging science as the future direction of tissue transfer technology.”
About Dr. Joel Aronowitz
Dr. Joel Aronowitz is a leading plastic surgeon in practice for over twenty-five years and holding many leadership positions including Chief of the Division of Plastic Surgery at Cedars-Sinai for ten years, the Board of the American Society of Breast Disease and teaching appointments at USC Keck School of Medicine. A graduate of the accelerated MD program at the prestigious Baylor College of Medicine in Texas, Dr. Aronowitz is certified as a Diplomate of the American Board of Plastic Surgery; an Ambassador of the American Society of Plastic Surgeons; a member of the American Association of Plastic Surgeons, The Society of Bariatric Plastic Surgeons and California Society of Plastic Surgeons. Dr. Aronowitz is also the founder of the Breast Preservation Foundation, a non-profit organization aimed at reducing the unnecessary disfigurement of breast cancer surgery through increased awareness of oncoplastic techniques, and the University Stem Cell Center, the first outpatient surgical center stem cell laboratory. His cutting edge procedures are consistently featured in national media outlets including CNN, The Dr. Oz Show, The Doctors, KNBC in Los Angeles, The New York Times, People Magazine and many others. For more information on Dr. Aronowitz, his practice and innovative procedures, please visit www.aronowitzmd.com.